Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cancer Discovery|May 13, 2015
Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal CancerRodrigo Dienstmann, Amita Patnaik, Rocio Garcia-Carbonero, et al.
NPJ Precision Oncology|November 6, 2022
Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patientsTessa J J de Bitter, Philip R de Reuver, Elise A J de Savornin Lohman, et al.
Gastroenterology|June 15, 2015
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1Rachel S van der Post, Ingrid P Vogelaar, Peggy Manders, et al.
Methods and Protocols|March 22, 2022
Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow ProtocolDaphne A J J Driessen, Didi J J M de Gouw, Rutger C H Stijns, et al.
Histopathology|June 19, 2026
Diagnostic impact and reproducibility of p53 immunohistochemistry in Barrett's oesophagus: results of the Dutch Esophageal Pathology Panel (DEPP)Ylva A Weeda, Sarah M Issa, Hans Halfwerk, et al.
Nature Communications|May 14, 2025
Unraveling mutagenic processes influencing the tumor mutational patterns of individuals with constitutional mismatch repair deficiencyDilys D Weijers, Snežana Hinić, Emma Kroeze, et al.
Endoscopy|June 7, 2022
Bite-on-bite biopsies for the detection of residual esophageal cancer after neoadjuvant chemoradiotherapyRuben D van der Bogt, Berend J van der Wilk, Lindsey Oudijk, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 10, 2021
Axial slicing versus bivalving in the pathological examination of pancreatoduodenectomy specimens (APOLLO): a multicentre randomized controlled trialStijn van Roessel, Eline C Soer, Susan van Dieren, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 16, 2024
The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2Snežana Hinić, Cezary Cybulski, Rachel S Van der Post, et al.
Journal of Medical Genetics|January 14, 2018
Role of germline aberrations affecting <i>CTNNA1</i>, <i>MAP3K6</i> and <i>MYD88</i> in gastric cancer susceptibilityRobbert D A Weren, Rachel S van der Post, Ingrid P Vogelaar, et al.
Pageof 9